Anna
Mathew, MD, MPH, FRCPC

About the researcher:

Specialty:

Nephrologist

Dr. Anna Mathew is an Assistant Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and a faculty member in the Division of Kidney Diseases and Hypertension.  In addition to working as a clinical nephrologist, she also attained an MPH degree in Quantitative Methods.   Her research interests lie in the clinical outcomes of patients with chronic kidney disease and end stage renal disease on dialysis.  She uses large datasets to conduct epidemiologic research, and has studied fracture rates in dialysis patients as well as mortality and graft loss after renal transplant. Her current major work is on readmission to hospital in dialysis patients, as well as an in-depth analysis of fractures in dialysis patients.

Research Interests:

  • Dialysis modality choice in late stage CKD
  • Mineral and Bone disease in CKD
  • Readmissions in end stage renal disease

Research focus:

Research training opportunities for residents

  • Conduct and publish systematic review and meta-analysis
  • Engage in ongoing large epidemiologic studies of clinical outcomes in dialysis patients

Research training opportunities for fellows

  • Conduct and publish systematic review and meta-analysis
  • Engage in ongoing large epidemiologic studies of clinical outcomes in dialysis patients

Education

University of Toronto

Degree: MD

University of Western Ontario

Degree: Internship/Residency
Field of study: Internal Medicine

University of Western Ontario

Degree: Fellowship
Field of study: Nephrology

Harvard University

Degree: MPH
Field of study: Quantitative Methods

Honors and awards

01/01/1014 - 12/31/2015

New York Department of Education - ECRIP

Publications

  1. Fishbane S, Mathew A, Vaziri ND. Iron toxicity: relevance for dialysis patients.  Nephrol Dial Transplant. 2014;29(2):255-9.
  2. Wagner J, Jhaveri KD, Rosen L, Sunday S, Mathew AT, Fishbane S. Increased bone fractures among elderly United States hemodialysis patients. Nephrol Dial Transplant. 2014;29(1):146-51. 
  3. Carotid endarterectomy benefits patients with CKD and symptomatic high-grade stenosis.
    Mathew A, Eliasziw M, Devereaux PJ, Merino JG, Barnett HJ, Garg AX; North American Symptomatic Carotid Endarterectomy Trial (NASCET) Collaborators.  J Am Soc Nephrol. 2010;21(1):145-52
  4. Nevis IF, Mathew A, Novick RJ et al. Optimal method of coronary revascularization in patients receiving dialysis: systematic review.  Clin J Am Soc Nephrol. 2009;4(2):369-78.
  5. A Mathew, P J Devereaux, A O'Hare et al. Chronic kidney disease and postoperative mortality: A systematic review and meta-analysis.  Kid International. 2008; 73, 1069–1081;